Abel Hall, LLC Q1 2025 Filing

Filed May 6, 2025

Portfolio Value

$165.7B

Holdings

202

Report Date

Q1 2025

Filing Type

13F-HR

All Holdings (202 positions)

#StockSharesValue% PortfolioType
201
OVIDOVID THERAPEUTICS INC
10,238$3.2M0.00%
202
LYRALYRA THERAPEUTICS INC
12,214$1.5M0.00%
PreviousPage 3 of 3